Toxicological Assessment and Risk Management of Pharmaceutical Impurities

ABSTRACT

The presence of impurities in pharmaceutical products poses significant toxicological and regulatory concerns, necessitating systematic assessment and risk management strategies. Pharmaceutical impurities, which may arise from synthesis, degradation, or contamination, can compromise drug safety and efficacy. This report provides a concise overview of the principles underlying the toxicological evaluation of these impurities, emphasizing Threshold of Toxicological Concern (TTC) approaches, structure-activity relationships, and genotoxicity assessment. Regulatory frameworks, including guidelines from the International Council for Harmonisation (ICH) Q3A/B, are discussed to highlight standardised limits and reporting requirements. Risk management strategies focus on identifying, quantifying, and controlling impurities throughout the drug development and manufacturing lifecycle. Analytical techniques such as High-Performance Liquid Chromatography (HPLC), mass spectrometry, and Nuclear Magnetic Resonance (NMR) spectroscopy are crucial for accurate detection and characterisation of trace-level impurities. The integration of predictive toxicology models and in vitro assays aids in prioritising impurities that pose significant health risks, enabling efficient allocation of resources for a detailed investigation. The report also outlines application of risk-based impurity assessment, demonstrating how a combination of toxicological data, exposure analysis, and regulatory guidance can inform safe pharmaceutical development. The effective management of pharmaceutical impurities is essential for ensuring patient safety, regulatory compliance, and the sustained quality of therapeutic products. The report underscores the need for continued advancements in analytical methodologies and predictive toxicology to address emerging challenges in impurity risk assessment.

KEYWORDS

• Genotoxicity
• Pharmaceutical impurities
• Risk management
• Threshold of toxicological
• concern
• Toxicological assessment

Showing references and in-text citations exactly as published.

• DOI10.5530/bems.12.2.8Copy

RELATED ARTICLES

Matched on section and article type within this issue of BEMSR.

• Article · VOLUME 12, ISSUE 2How Data and AI Can Optimise Pharmaceutical Supply ChainsArun HS Kumar* · pp. 47–52Brief ReportSame type: Article
• Article · VOLUME 12, ISSUE 2Beyond Outbreak Counts: A Novel Epidemiological Classification of Major Animal Diseases Using Loss-to-Case and Cases-per-Outbreak RatiosArun HS Kumar* · pp. 53–57Brief ReportSame type: Article
• Article · VOLUME 12, ISSUE 2The Koebner Phenomenon and First Episode of Psoriasis after Contact with Cold Metal in Fitzpatrick Type II SkinPriya Kadam, Irrum Aneela · pp. 30–32Same type: Article
• Article · VOLUME 12, ISSUE 2Comparative Analysis of Vascular Density in the Femoral Head Ligament of the Dog, Sheep, and GoatImani Stanard, Hazem Almhanna, Aqeel Mohsin Mahdi Al-Mahmodi, David Kilroy­, Arun HS Kumar­ · pp. 58–64Same type: Article